TGF-β1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3ε mAb- and CD28 mAb-activated splenocytes and thymocytes

Immunopharmacology

Volumn 48, Issue 2, 2000, Pages 101-115

  McKarns, Susan C ^a   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

CD28; CD3; Interleukin 2; Proliferation; Splenocyte; T cell; TGF 1; Thymocyte

Indexed keywords

INTERLEUKIN 2; MONOCLONAL ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTES; THYMIDINE; THYMUS GLAND; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRITIUM;

EID: 0034691541     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00183-1     Document Type: Article

References (40)

1. Adams D., Hathaway M., Shaw J., Burnett D., Elias E., Strain A. Transforming growth factor-beta induces human T lymphocyte migration in vitro. J. Immunol. 147:1991;609-612.
2. Ahmad S., Choudhry M., Shanker R., Sayeed N. Transforming growth factor-beta negatively regulates T-cell responses in sepsis. FEBS Lett. 402:1997;213-218.
3. Aoki N., Inobe M., Murakami M., Abe R., Iizuka H. The functional role of B7 molecules on the induction of thymocyte activation and apoptosis. Microbiol. Immunol. 42:1998;555-565.
4. Bacsi A., Aranyosi J., Beck Z., Ebbesen P., Andirko I., Szabo J., Lampe L., Kiss J., Gergely L., Toth F. Placental macrophase contact potentiates the complete replicative cycle of human cytomegalovirus in syncytiotrophoblast cells: role of interleukin-8 and transforming growth factor beta-1. J. Interferon Cytokine Res. 10:1999;1153-1160.
5. Boise L., Noel P.J., Thompson C.B. CD28 and apoptosis. Curr. Opin. Immunol. 7:1995;620-625.
6. Brabletz T., Pfeuffer I., Schorr E., Siebelt F., Wirth T., Serfling E. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T-cells through a noncanonical octomer-binding site. Mol. Cell Biol. 13:1993;1155-1162.
7. Cerwenka A., Bevec D., Majdic O., Knapp W., Holter W. TGF-β is a potent inducer of human effector T cells. J. Immunol. 153:1994;4367-4377.
8. 1. J. Immunol. 156:1996;459-464.
9. Chernajovsky Y., Adams G., Triantaphyllopoulos K., Ledda M.F., Podhajer O.L. Pathogenic lymphoid cells engineered to express TGF-β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther. 4:1997;553-559.
10. 1-deficient mice. J. Immunol. 153:1994;1936-1946.
11. 1. Toxicol. Appl. Pharmacol. 1994;98-107.
12. DeLaney B., Woo S.K., Yang K.H., Strom S.C., Kaminski N.E. Hepatocyte growth factor enhances B-cell activity. Life Sci. 53:1993;PL89-PL93.
13. Diebold R., Eis M., Yin M., Ormsby I., Boivin G., Darrow B., Saffitz J., Doetschman T. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. U S A. 92:1995;12215-12219.
14. Dunnett C. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
15. 1. J. Exp. Med. 166:1988;571-576.
16. Espevik T., Waage A., Faxvaag A., Shalaby M. Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 and transforming growth factor-β Cell. Immunol. 126:1990;47-56.
17. Habu K., Nakayama-Yamada J., Asano M., Saijo S., Itagaki K., Horai R., Yamamoto H., Sekiguchi T., Nosaka T., Hatanaka M., Iwadura Y. The human T leukemia virus type I-tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic mice. J. Immunol. 162:1999;2956-2963.
18. Hartsough M.T., Mulder K.M. Transforming growth factor-β signaling in epithelial cells. Pharmacol. Ther. 75:1997;21-41.
19. Kaminski N.E., Koh W.S., Yang K.H., Lee M., Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48:1994;1899-1908.
20. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., Fauci A.S. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1986;1037-1050.
21. Kulkarni A.B., Huh C.H., Becker D., Geiser A., Lyght M., Flanders F.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U S A. 90:1993;770-774.
22. 1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:1996;2109-2119.
23. Letterio J.L., Roberts A.B. Regulation of the immune responses by TGF-β Annu. Rev. Immunol. 16:1998;137-161.
24. 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J. Immunol. 145:1990;1415-1422.
25. McCartney-Francis N., Frazier-Jessen M., Wahl S. TGF-β: a balancing act. Int. Rev. Immunol. 16:1998;553-580.
26. Miyazono K., ten Dijke P., Tamashita H., Heldin C. Signal transduction via serine/threonine kinase receptors. Semin. Cell Biol. 6:1994;389-398.
27. 1 mechanism. Blood. 85:1995;3594-3601.
28. Navarrete Santos, Kehlen A., Schutte W., Langner J., Riemann D. Regulation by transforming growth factor-beta1 of class II mRNA and protein expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Int. Immunol. 10:1998;601-607.
29. Piek E., Heldrin C.-H., ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. J. FASEB. 13:1999;2105-2124.
30. Rich S., van Hood N., Lee H.M. Role of alpha 5 beta 1 integrin in TGF-β1-costimulated CD8+T-cell growth and apoptosis. J. Immunol. 157:1996;2916-2923.
31. Sad S., Mosmann T. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:1997;3514-3522.
32. Saltis J. TGF-β: receptors and cell cycle arrest. Mol. Cell. Endocrinol. 116:1996;227-232.
33. Swain S.L., Hutson S., Tonkonogy S., Weinberg A. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:1991;2991-3000.
34. Wahl S.M. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 12:1992;61-74.
35. Wahl S.M. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 1994;1587-1590.
36. Wahl S.M., Allen J.B., McCartney-Francis N., Morganti-Kossmann M.C., Kossmann T., Ellingsworth L., Mai U.E., Mergenhagen S.E., Orenstein J.M. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173:1991;981-991.
37. Wahl S., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B. Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U.S.A. 84:1987;5788-5792.
38. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science. 270:1995;2008-2011.
39. 1 knockout mouse. Blood. 87:1996;1439-1445.
40. Zhang X., Giangreco L., H.E. B., Dargan C.M., Swain S.L. Control for CD4 effector fate: transforming growth factor β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 182:1995;699-709.